Connections between MGUS and Peripheral Neuropathy:
Direct Antibody Activity**: The monoclonal protein (M protein) produced in MGUS can sometimes have antibody activity against components of the peripheral nervous system. For instance, IgM MGUS is notorious for producing antibodies that target myelin-associated glycoprotein (MAG), a protein in the myelin sheath around nerves, leading to demyelination and nerve dysfunction.
- **Autoimmune Reaction**: The M protein might trigger an autoimmune response where the immune system attacks nerve tissue.
2. **Amyloidosis**:
- In some cases, the light chains (parts of the M protein) can form amyloid deposits in nerve tissues, leading to a type of amyloid neuropathy. Amyloid deposits can physically disrupt nerve function by replacing normal tissue structure.
3. **Toxic Effects**:
- The M protein or its fragments might have direct toxic effects on nerve cells, though this mechanism is less understood and less common.
4. **Vascular Compromise**:
- In rare instances, the M protein might increase blood viscosity or cause small vessel disease, leading to reduced blood flow and oxygen to nerves, thus causing ischemic neuropathy.
Monoclonal Gammopathy of Undetermined Significance (MGUS),
CRISPR stands for “clustered interspaced short palindromic repeats.” Biologists use the term to describe the “genetic appearance” of a system that was discovered in microbes – including bacteria and archaea – as early as 1987. For a long time, no one really understood what it did, but around 2005, researchers discovered CRISPR is an immune system. It’s used by microbes to help protect themselves from invading viruses. To stop the invaders, the microbes use CRISPR to recognize and eliminate specific trespassers.